While several cell types contribute to anti-tumor responses, CD4 T-helper 1 (TH1) cells and CD8 cytotoxic T-lymphocytes (CTL), are critical in mediating anti-tumor immunity due to their ability to recognize tumor antigens and mediate tumor killing. The gene discussed is CD8A; the disease is neoplasm.